Autoimmune myelitis in a CLL patient undergoing treatment with ibrutinib

MeSH terms

• Adenine / analogs & derivatives
• Antibodies, Monoclonal, Murine-Derived / administration & dosage
• Antibodies, Monoclonal, Murine-Derived / adverse effects
• Antineoplastic Combined Chemotherapy Protocols / administration & dosage
• Antineoplastic Combined Chemotherapy Protocols / adverse effects
• Autoimmune Diseases* / chemically induced
• Autoimmune Diseases* / diagnostic imaging
• Autoimmune Diseases* / drug therapy
• Cyclophosphamide / administration & dosage
• Cyclophosphamide / adverse effects
• Doxorubicin / administration & dosage
• Doxorubicin / adverse effects
• Humans
• Leukemia, Lymphocytic, Chronic, B-Cell* / diagnostic imaging
• Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
• Male
• Middle Aged
• Myelitis* / chemically induced
• Myelitis* / diagnostic imaging
• Myelitis* / drug therapy
• Piperidines
• Prednisone / administration & dosage
• Prednisone / adverse effects
• Pyrazoles* / administration & dosage
• Pyrazoles* / adverse effects
• Pyrimidines* / administration & dosage
• Pyrimidines* / adverse effects
• Rituximab
• Vincristine / administration & dosage
• Vincristine / adverse effects